Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
David Schteingart
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Anatomy
Sign-in to see full Profile
Network (preview)
17
starkman, monica
10
Gross, Milton
6
Chandler, William
5
Counsell, Raymond
5
Gebarski, Stephen
5
Giordani, Bruno
5
Shapiro, Brahm
4
Wotring, LL
3
Giordano, Thomas
3
Berent, Stanley
2
Barkan, Ariel
2
Doherty, Gerard
2
McKeever, Paul
2
Schork, Anthony
2
Francis, Isaac
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of David Schteingart (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Hodish Israel; Giordano Thomas J; Starkman Monica N; Schteingart David E
Location of ectopic adrenocortical hormone-secreting tumors causing Cushing's syndrome in the paranasal sinuses.
Head & neck 2009;31(5):699-706.
-
2007: Starkman Monica N; Giordani Bruno; Gebarski Stephen S; Schteingart David E
Improvement in mood and ideation associated with increase in right caudate volume.
Journal of affective disorders 2007;101(1-3):139-47.
-
2007: Schteingart David E
Adjuvant mitotane therapy of adrenal cancer - use and controversy.
The New England journal of medicine 2007;356(23):2415-8.
-
2007: Hook Julie N; Giordani Bruno; Schteingart David E; Guire Kenneth; Giles Jodie; Ryan Kelley; Gebarski Stephen S; Langenecker Scott A; Starkman Monica N
Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease.
Journal of the International Neuropsychological Society : JINS 2007;13(1):21-9.
-
2006: Mackie Gavin C; Shulkin Barry L; Ribeiro Raul C; Worden Francis P; Gauger Paul G; Mody Rajen J; Connolly Len P; Kunter Ghada; Rodriguez-Galindo Carlos; Wallis Jerold W; Hurwitz Craig A; Schteingart David E
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.
The Journal of clinical endocrinology and metabolism 2006;91(7):2665-71.
-
2006: Clark Orlo H; Ajani Jaffer; Benson Al B; Byrd David; Doherty Gerard M; Engstrom Paul F; Ettinger David S; Gibbs John F; Heslin Martin J; Kandeel Fouad; Kessinger Anne; Kulke Matthew H; Kvols Larry; Nemcek Albert A; Olson John A; Ratliff Thomas W; Saltz Leonard; Schteingart David E; Shah Manisha H; Shibata Stephen;
Neuroendocrine tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(2):102-38.
-
2005: Schteingart D E; Doherty G M; Gauger P G; Giordano T J; Hammer G D; Korobkin M; Worden F P
Management of patients with adrenal cancer: recommendations of an international consensus conference.
Endocrine-related cancer 2005;12(3):667-80.
-
2005: Schteingart David E
The 50th anniversary of the identification of primary aldosteronism: a retrospective of the work of Jerome W. Conn.
The Journal of laboratory and clinical medicine 2005;145(1):12-6.
-
2003: Starkman Monica N; Giordani Bruno; Gebarski Stephen S; Schteingart David E
Improvement in learning associated with increase in hippocampal formation volume.
Biological psychiatry 2003;53(3):233-8.
-
2003: Chandler William F; Barkan Ariel L; Schteingart David E
Management options for persistent functional tumors.
Neurosurgery clinics of North America 2003;14(1):139-45, viii.
-
2002: Douyon Liselle; Schteingart David E
Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion.
Endocrinology and metabolism clinics of North America 2002;31(1):173-89.
-
2001: Starkman M N; Giordani B; Berent S; Schork M A; Schteingart D E
Elevated cortisol levels in Cushing's disease are associated with cognitive decrements.
Psychosomatic medicine 2001;63(6):985-93.
-
2001: Schteingart D E
Current perspective in the diagnosis and treatment of adrenocortical carcinoma.
Reviews in endocrine & metabolic disorders 2001;2(3):323-33.
-
2001: Schteingart D E; Giordano T J; Benitez R S; Burdick M D; Starkman M N; Arenberg D A; Strieter R M
Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome.
The Journal of clinical endocrinology and metabolism 2001;86(8):3968-74.
-
2001: Stratakis C A; Taymans S E; Schteingart D; Haddad B R
Segmental uniparental isodisomy (UPD) for 2p16 without clinical symptoms: implications for UPD and other genetic studies of chromosome 2.
Journal of medical genetics 2001;38(2):106-9.
-
2000: Schteingart D E
Conventional and novel strategies in the treatment of adrenocortical cancer.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2000;33(10):1197-200.
-
2000: Schteingart D E
Management approaches to adrenal incidentalomas. A view from Ann Arbor, Michigan.
Endocrinology and metabolism clinics of North America 2000;29(1):127-39, ix-x.
-
1999: Starkman M N; Giordani B; Gebarski S S; Berent S; Schork M A; Schteingart D E
Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease.
Biological psychiatry 1999;46(12):1595-602.
-
1999: Assi Z I; Bohnen N I; Schteingart D E; Gross M D; Shapiro B
Testicular I-131 6beta-iodomethyl-19-norcholesterol uptake in a patient with adrenogenital syndrome.
Clinical nuclear medicine 1999;24(6):464.
-
1997: Cai W; Counsell R E; Schteingart D E; Sinsheimer J E; Vaz A D; Wotring L L
Adrenal proteins bound by a reactive intermediate of mitotane.
Cancer chemotherapy and pharmacology 1997;39(6):537-40.
-
1996: Kronfol Z; Starkman M; Schteingart D E; Singh V; Zhang Q; Hill E
Immune regulation in Cushing's syndrome: relationship to hypothalamic-pituitary-adrenal axis hormones.
Psychoneuroendocrinology 1996;21(7):599-608.
-
1996: Sinsheimer J E; Counsell R E; Cai W; Gopalaswamy R; Mahalakshmi P; Piñeiro-Sánchez M L; Ruangwises N; Schteingart D E
Gas chromatographic-electron capture determination of 2,4'-dichlorodiphenylacetic acid from in-vitro adrenal transformations of mitotane and its analogs.
Journal of pharmaceutical and biomedical analysis 1996;14(7):861-6.
-
1995: Cameron O G; Starkman M N; Schteingart D E
The effect of elevated systemic cortisol levels on plasma catecholamines in Cushing's syndrome patients with and without depressed mood.
Journal of psychiatric research 1995;29(5):347-60.
-
1995: Cai W; Benitez R; Counsell R E; Djanegara T; Schteingart D E; Sinsheimer J E; Wotring L L
Bovine adrenal cortex transformations of mitotane [1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; o,p'-DDD] and its p,p'- and m,p'-isomers.
Biochemical pharmacology 1995;49(10):1483-9.
-
1995: Cai W; Counsell R E; Djanegara T; Schteingart D E; Sinsheimer J E; Wotring L L
Metabolic activation and binding of mitotane in adrenal cortex homogenates.
Journal of pharmaceutical sciences 1995;84(2):134-8.
-
1994: Gross M D; Shapiro B; Francis I R; Glazer G M; Bree R L; Arcomano M A; Schteingart D E; McLeod M K; Sanfield J A; Thompson N W
Scintigraphic evaluation of clinically silent adrenal masses.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(7):1145-52.
-
1993: Dobs A S; Sarma P S; Schteingart D
Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Metabolism: clinical and experimental 1993;42(9):1146-52.
-
1993: Schteingart D E; Sinsheimer J E; Counsell R E; Abrams G D; McClellan N; Djanegara T; Hines J; Ruangwises N; Benitez R; Wotring L L
Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma.
Cancer chemotherapy and pharmacology 1993;31(6):459-66.
-
1992: Shipley J E; Schteingart D E; Tandon R; Starkman M N
Sleep architecture and sleep apnea in patients with Cushing's disease.
Sleep 1992;15(6):514-8.
-
1992: Starkman M N; Gebarski S S; Berent S; Schteingart D E
Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome.
Biological psychiatry 1992;32(9):756-65.
-
1992: Pasieka J L; McLeod M K; Thompson N W; Gross M D; Schteingart D E
Adrenal scintigraphy of well-differentiated (functioning) adrenocortical carcinomas: potential surgical pitfalls.
Surgery 1992;112(5):884-90.
-
1992: Starkman M N; Schteingart D E; Schork M A
Discordant changes in plasma ACTH and beta-lipotropin/beta-endorphin levels in Cushing's disease patients with depression.
Psychoneuroendocrinology 1992;17(6):619-26.
-
1992: Shipley J E; Schteingart D E; Tandon R; Pande A C; Grunhaus L; Haskett R F; Starkman M N
EEG sleep in Cushing's disease and Cushing's syndrome: comparison with patients with major depressive disorder.
Biological psychiatry 1992;32(2):146-55.
-
1992: Schteingart D E
Effectiveness of phenylpropanolamine in the management of moderate obesity.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1992;16(7):487-93.
-
1991: Schteingart D E
Ectopic secretion of peptides of the proopiomelanocortin family.
Endocrinology and metabolism clinics of North America 1991;20(3):453-71.
-
1991: Lampman R M; Schteingart D E
Effects of exercise training on glucose control, lipid metabolism, and insulin sensitivity in hypertriglyceridemia and non-insulin dependent diabetes mellitus.
Medicine and science in sports and exercise 1991;23(6):703-12.
-
1989: Schteingart D E
Cushing's syndrome.
Endocrinology and metabolism clinics of North America 1989;18(2):311-38.
-
1988: Fig L M; Gross M D; Shapiro B; Ehrmann D A; Freitas J E; Schteingart D E; Glazer G M; Francis I R
Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
Annals of internal medicine 1988;109(7):547-53.
-
1988: Mountz J M; Gross M D; Shapiro B; Barkan A L; Woodbury M C; Schteingart D E; Ayers J W
Scintigraphic localization of ovarian dysfunction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(10):1644-50.
-
1987: Schteingart D E; Chandler W F; Lloyd R V; Ibarra-Perez G
Cushing's syndrome caused by an ectopic pituitary adenoma.
Neurosurgery 1987;21(2):223-7.
-
1987: Funakoshi A; Schteingart D E; Vinik A I
Effect of insulin on motilin release in man.
The Tohoku journal of experimental medicine 1987;152(3):247-51.
-
1987: Lampman R M; Schteingart D E; Santinga J T; Savage P J; Hydrick C R; Bassett D R; Block W D
The influence of physical training on glucose tolerance, insulin sensitivity, and lipid and lipoprotein concentrations in middle-aged hypertriglyceridaemic, carbohydrate intolerant men.
Diabetologia 1987;30(6):380-5.
-
1987: Chandler W F; Schteingart D E; Lloyd R V; McKeever P E; Ibarra-Perez G
Surgical treatment of Cushing's disease.
Journal of neurosurgery 1987;66(2):204-12.
-
1986: Starkman M N; Schteingart D E; Schork M A
Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome.
Psychiatry research 1986;19(3):177-88.
-
1986: Schteingart D E; Lloyd R V; Akil H; Chandler W F; Ibarra-Perez G; Rosen S G; Ogletree R
Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion.
The Journal of clinical endocrinology and metabolism 1986;63(3):770-5.
-
1986: Lloyd R V; Chandler W F; McKeever P E; Schteingart D E
The spectrum of ACTH-producing pituitary lesions.
The American journal of surgical pathology 1986;10(9):618-26.
-
1986: Starkman M N; Schteingart D E; Schork M A
Correlation of bedside cognitive and neuropsychological tests in patients with Cushing's syndrome.
Psychosomatics 1986;27(7):508-11.
-
1986: Vinik A I; Seino S; Funakoshi A; Schwartz J; Matsumoto M; Schteingart D E; Fu Z Z; Tsai S T
Familial hyperinsulinemia associated with secretion of an abnormal insulin, and coexistence of insulin resistance in the propositus.
The Journal of clinical endocrinology and metabolism 1986;62(4):645-52.
-
1986: Lampman R M; Schteingart D E; Foss M L
Exercise as a partial therapy for the extremely obese.
Medicine and science in sports and exercise 1986;18(1):19-24.
-
1986: Chandler W F; Schteingart D E
Controversies in the management of Cushing's disease.
Clinical neurosurgery 1986;33():553-62.
-
1984: DeStephano D B; Lloyd R V; Schteingart D E
Cushing's syndrome produced by a bronchial carcinoid tumor.
Human pathology 1984;15(9):890-2.
-
1984: Gross M D; Shapiro B; Freitas J E; Ayers J; Swanson D P; Woodbury M C; Schteingart D E; Beierwaltes W H
The relationship of I-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal cortical uptake to indices of androgen secretion in women with hyperandrogenism.
Clinical nuclear medicine 1984;9(5):264-70.
-
1982: Schteingart D E; Motazedi A; Noonan R A; Thompson N W
Treatment of adrenal carcinomas.
Archives of surgery (Chicago, Ill. : 1960) 1982;117(9):1142-6.
-
1981: Schteingart D E
The medical management of obesity.
Michigan medicine 1981;80(17):322-4.
-
1981: Schteingart D E; Seabold J E; Gross M D; Swanson D P
Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.
The Journal of clinical endocrinology and metabolism 1981;52(6):1156-61.
-
1981: Gross M D; Valk T W; Freitas J E; Swanson D P; Schteingart D E; Beierwaltes W H
The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.
The Journal of clinical endocrinology and metabolism 1981;52(6):1062-6.
-
1981: Starkman M N; Schteingart D E; Schork M A
Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels.
Psychosomatic medicine 1981;43(1):3-18.
-
1981: Starkman M N; Schteingart D E
Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.
Archives of internal medicine 1981;141(2):215-9.
-
1981: Gross M D; Freitas J E; Swanson D P; Woodbury M C; Schteingart D E; Beierwaltes W H
Dexamethasone-suppression adrenal scintigraphy in hyperandrogenism: concise communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1981;22(1):12-7.
-
1981: Tulin-Silver J; Schteingart D E; Mathews K P
Effect of theophylline on cortisol secretion.
The Journal of allergy and clinical immunology 1981;67(1):45-50.
-
1980: Whelan T B; Schteingart D E; Starkman M N; Smith A
Neuropsychological deficits in Cushing's syndrome.
The Journal of nervous and mental disease 1980;168(12):753-7.
-
1980: Valk T W; Gross M D; Freitas J E; Swanson D P; Schteingart D E; Beierwaltes W H
The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(11):1069-72.
-
1980: Schteingart D E; McKenzie A K
Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
The Journal of clinical endocrinology and metabolism 1980;51(5):1195-8.
-
1980: Schteingart D E; Tsao H S; Taylor C I; McKenzie A; Victoria R; Therrien B A
Sustained remission of Cushing's disease with mitotane and pituitary irradiation.
Annals of internal medicine 1980;92(5):613-9.
-
1980: Schteingart D E; Tsao H S
Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma.
The Journal of clinical endocrinology and metabolism 1980;50(5):961-6.
-
1980: Schteingart D E
Suppression of cortisol secretion by human growth hormone.
The Journal of clinical endocrinology and metabolism 1980;50(4):721-5.
-
1980: Foss M L; Lampman R M; Schteingart D E
Extremely obese patients: improvements in exercise tolerance with physical training and weight loss.
Archives of physical medicine and rehabilitation 1980;61(3):119-24.
-
1979: Schteingart D E; McKenzie A K; Victoria R S; Tsao H S
Suppression of insulin secretion by protein deprivation in obesity.
Metabolism: clinical and experimental 1979;28(9):943-9.
-
1979: Stoffer S S; Weitzman R; Schteingart D E
Adrenalectomy and Cushing's disease.
Archives of surgery (Chicago, Ill. : 1960) 1979;114(8):980.
-
1979: Schteingart D E; Woodbury M C; Tsao H S; McKenzie A K
Virilizing syndrome associated with an adrenal cortical adenoma secreting predominantly testosterone.
The American journal of medicine 1979;67(1):140-6.
-
1979: Schteingart D E; McKenzie A K; Victoria R S; Tsao H S
Suppression of insulin secretion by protein deprivation in obesity.
Advances in experimental medicine and biology 1979;119():125-35.
-
1978: Tucker R P; Weinstein H E; Schteingart D E; Starkman M N
EEG changes and serum cortisol levels in cushing's syndrome.
Clinical EEG (electroencephalography) 1978;9(1):32-7.
-
1976: Foss M L; Lampman R M; Schteingart D
Physical training program for rehabilitating extremely obese patients.
Archives of physical medicine and rehabilitation 1976;57(9):425-9.
-
1975: Foss M L; Lampman R M; Watt E; Schteingart D E
Initial work tolerance of extremely obese patients.
Archives of physical medicine and rehabilitation 1975;56(2):63-7.
-
1974: Reif V D; Sinsheimer J E; Ward J C; Schteingart D E
Aromatic hydroxylation and alkyl oxidation in metabolism of mitotane (o,p'-DDD) in humans.
Journal of pharmaceutical sciences 1974;63(11):1730-6.
-
1974: Moses D C; Schteingart D E; Sturman M F; Beierwaltes W H; Ice R D
Efficacy of radiocholesterol imaging of the adrenal glands in Cushing's syndrome.
Surgery, gynecology & obstetrics 1974;139(2):201-4.
-
1974: Herwig K R; Schteingart D E
Successful removal of adrenal remnant localized by 131-I-19-iodocholesterol.
The Journal of urology 1974;111(6):713-4.
-
1973: Herwig K R; Conn J W; Schteingart D E; Beierwaltes W H
Localization of adrenal tumors by photoscanning.
The Journal of urology 1973;109(1):2-4.
-
1972: Schteingart D E; Conn J W; Lieberman L M; Beierwaltes W H
Persistent or recurrent Cushing's syndrome after "total" adrenalectomy: adrenal photoscanning for residual tissue.
Archives of internal medicine 1972;130(3):384-7.
-
1972: Schteingart D E; Conn J W; Orth D N; Harrison T S; Fox J E; Bookstein J J
Secretion of ACTH and -MSH by an adrenal medullary paraganglioma.
The Journal of clinical endocrinology and metabolism 1972;34(4):676-83.
-
1972: Sinsheimer J E; Guilford J; Bobrin L J; Schteingart D E
Identification of o,p'-dichlorodiphenyl acetic acid as a urinary metabolite of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane.
Journal of pharmaceutical sciences 1972;61(2):314-6.
-
1968: Schteingart D E; Oberman H A; Friedman B A; Conn J W
Adrenal cortical neoplasms producing cushing's syndrome. A clinicopathologic study.
Cancer 1968;22(5):1005-13.
-
1967: Schteingart D E; Conn J W
Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
The Journal of clinical endocrinology and metabolism 1967;27(12):1657-66.
-
1967: Reuter S R; Blair A J; Schteingart D E; Bookstein J J
Adrenal venography.
Radiology 1967;89(5):805-14.
-
1967: Schteingart D E
Adrenal function and disease in pregnancy.
Clinical obstetrics and gynecology 1967;10(1):88-105.
-
1966: Schteingart D E; Cash R; Conn J W
Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome.
JAMA : the journal of the American Medical Association 1966;198(9):1007-10.
-
1966: Schteingart D E; Conn J W
[Characteristics of the adrenal cortex hyperfunction in obesity]
Prensa médica argentina 1966;53(9):978-90.
-
1965: Schteingart D E; Conn J W
Characteristics of the increased adrenocortical function observed in many obese patients.
Annals of the New York Academy of Sciences 1965;131(1):388-403.
-
1964: SCHTEINGART D E; GREGERMAN R Y; CONN J W
[COMPARISON OF THE CHARACTERISTICS OF ADRENOCORTICAL HYPERFUNCTION IN SIMPLE OBESITY AND IN CUSHING'S SYNDROME.]
El Día médico 1964;36():306-7.
-
1963: CRAIG A P; SCHTEINGART D E; SHAW M W
GONADAL DYSGENESIS WITH XUXX MOSAICISM AND A POSITIVE SEX CHROMATIN PATTERN.
The Journal of clinical endocrinology and metabolism 1963;23():752-8.
-
1963: SCHTEINGART D E; GREGERMAN R I; CONN J W
A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing's syndrome.
Metabolism: clinical and experimental 1963;12():484-97.
-
1961: FAJANS S S; SCHNEIDER J M; SCHTEINGART D E; CONN J W
The diagnostic value of sodium tolbutamide in hypoglycemic states.
The Journal of clinical endocrinology and metabolism 1961;21():371-86.
-
1960: SCHTEINGART D E; PERLMUTTER M; NUMEROFF M
Effect of diuretics upon the serum protein bound iodine and the thyroidal uptake of radioactive iodine.
The American journal of the medical sciences 1960;239():571-7.
-
1957: GUERRA C; KAPLAN A; LEMBERG A; SCHTEINGART D E; SINGERMAN A
[Acute poisoning caused by methyl chloride; refrigerating gas.]
Prensa médica argentina 1957;44(22):1671-6.
Sign-in to see more